- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- homo-tetramer
- Ligands
- 8 x MN: MANGANESE (II) ION(Non-covalent)
- 4 x CL: CHLORIDE ION(Non-functional Binders)
CL.3: 3 residues within 4Å:- Chain A: S.73, R.76, K.114
Ligand excluded by PLIPCL.8: 3 residues within 4Å:- Chain B: S.73, R.76, K.114
Ligand excluded by PLIPCL.13: 3 residues within 4Å:- Chain C: S.73, R.76, K.114
Ligand excluded by PLIPCL.18: 3 residues within 4Å:- Chain D: S.73, R.76, K.114
Ligand excluded by PLIP- 4 x KU2: 2-[(2S)-1-{[(2-chlorophenyl)sulfanyl]acetyl}pyrrolidin-2-yl]-5-hydroxy-6-oxo-N-(2-phenoxyethyl)-1,6-dihydropyrimidine-4 -carboxamide(Non-covalent)
KU2.4: 14 residues within 4Å:- Chain A: A.40, M.41, Y.44, E.46, A.57, I.58, H.61, E.81, D.109, E.120, I.121, Y.131
- Ligands: MN.1, MN.2
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:Y.44, A:E.46, A:A.57, A:H.61
- Hydrogen bonds: A:Y.131, A:Y.131
- pi-Stacking: A:Y.44
KU2.9: 14 residues within 4Å:- Chain B: A.40, M.41, Y.44, E.46, A.57, I.58, H.61, E.81, D.109, E.120, I.121, Y.131
- Ligands: MN.6, MN.7
7 PLIP interactions:7 interactions with chain B- Hydrophobic interactions: B:Y.44, B:E.46, B:A.57, B:H.61
- Hydrogen bonds: B:Y.131, B:Y.131
- pi-Stacking: B:Y.44
KU2.14: 14 residues within 4Å:- Chain C: A.40, M.41, Y.44, E.46, A.57, I.58, H.61, E.81, D.109, E.120, I.121, Y.131
- Ligands: MN.11, MN.12
7 PLIP interactions:7 interactions with chain C- Hydrophobic interactions: C:Y.44, C:E.46, C:A.57, C:H.61
- Hydrogen bonds: C:Y.131, C:Y.131
- pi-Stacking: C:Y.44
KU2.19: 14 residues within 4Å:- Chain D: A.40, M.41, Y.44, E.46, A.57, I.58, H.61, E.81, D.109, E.120, I.121, Y.131
- Ligands: MN.16, MN.17
7 PLIP interactions:7 interactions with chain D- Hydrophobic interactions: D:Y.44, D:E.46, D:A.57, D:H.61
- Hydrogen bonds: D:Y.131, D:Y.131
- pi-Stacking: D:Y.44
- 4 x SO4: SULFATE ION(Non-functional Binders)
SO4.5: 6 residues within 4Å:- Chain A: I.50, E.51, T.52, N.53, K.54, S.195
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:E.51, A:E.51, A:N.53, A:N.53, A:K.54, A:S.195
SO4.10: 6 residues within 4Å:- Chain B: I.50, E.51, T.52, N.53, K.54, S.195
6 PLIP interactions:6 interactions with chain B- Hydrogen bonds: B:E.51, B:E.51, B:N.53, B:N.53, B:K.54, B:S.195
SO4.15: 6 residues within 4Å:- Chain C: I.50, E.51, T.52, N.53, K.54, S.195
6 PLIP interactions:6 interactions with chain C- Hydrogen bonds: C:E.51, C:E.51, C:N.53, C:N.53, C:K.54, C:S.195
SO4.20: 6 residues within 4Å:- Chain D: I.50, E.51, T.52, N.53, K.54, S.195
6 PLIP interactions:6 interactions with chain D- Hydrogen bonds: D:E.51, D:E.51, D:N.53, D:N.53, D:K.54, D:S.195
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Beylkin, D. et al., Protein-Structure Assisted Optimization of 4,5-Dihydroxypyrimidine-6-Carboxamide Inhibitors of Influenza Virus Endonuclease. Sci Rep (2017)
- Release Date
- 2017-12-27
- Peptides
- Polymerase acidic protein: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- homo-tetramer
- Ligands
- 8 x MN: MANGANESE (II) ION(Non-covalent)
- 4 x CL: CHLORIDE ION(Non-functional Binders)
- 4 x KU2: 2-[(2S)-1-{[(2-chlorophenyl)sulfanyl]acetyl}pyrrolidin-2-yl]-5-hydroxy-6-oxo-N-(2-phenoxyethyl)-1,6-dihydropyrimidine-4 -carboxamide(Non-covalent)
- 4 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Beylkin, D. et al., Protein-Structure Assisted Optimization of 4,5-Dihydroxypyrimidine-6-Carboxamide Inhibitors of Influenza Virus Endonuclease. Sci Rep (2017)
- Release Date
- 2017-12-27
- Peptides
- Polymerase acidic protein: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A